2021 BioTech Digital Health Life Science 
Digital Health Global
OCTOBER 11, 2023
The acquisition immediately expands EVERSANA’s European operations and worldwide capabilities to help pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, or solve unique geographic and market-specific challenges.
Society for Participatory Medicine
JANUARY 27, 2022
Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. Market forces drove acceleration in digital health, specifically telemedicine, which were sorely needed for several years. Did you enjoy this post?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Lloyd Price
FEBRUARY 13, 2024
Exec Summary: Scotland has emerged as a global leader in the field of digital health and care, driven by a combination of factors: A strong foundation in medical innovation: Scotland boasts a rich history of medical breakthroughs, from the world's first cloned sheep (Dolly) to pioneering research in stem cell therapy.
Lloyd Price
SEPTEMBER 16, 2023
Exec Summary: Investment into the Scottish healthtech market in 2022 reached a record high of £705 million, surpassing the previous record of £626 million set in 2021. The country was one of the first in the UK to scrap prescription fees, and it is also leading the way in areas such as digital health and artificial intelligence.
Health Populi
MARCH 11, 2021
2021 is the 20th anniversary of the University of Michigan Center for Value-Based Insurance Design (V-BID). Note: I may be biased as a University of Michigan graduate of both the School of Public Health and Rackham School of Graduate Studies in Economics].
Expert insights. Personalized for you.
167 
Let's personalize your content